US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.590
  • -0.026-4.25%
Close Jun 20 16:00 ET
  • 0.605
  • +0.015+2.51%
Post 17:10 ET
47.16MMarket Cap-786P/E (TTM)

BioLine Rx Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
6.86M
4.8M
4.8M
0
0
0
0
0
0
0
Operating revenue
--6.86M
--4.8M
--4.8M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
1.46M
3.69M
0
0
Gross profit
5.4M
1.11M
0
0
Operating expense
15.42%10.22M
51.25%44.1M
54.47%12.97M
74.58%12.36M
30.43%9.92M
45.68%8.86M
17.68%29.16M
27.28%8.4M
13.85%7.08M
16.72%7.6M
Selling and administrative expenses
49.42%7.73M
171.83%31.23M
93.12%9.52M
255.48%9.63M
213.05%6.91M
214.60%5.17M
118.05%11.49M
244.69%4.93M
109.35%2.71M
60.63%2.21M
-Selling and marketing expense
63.71%6.34M
198.91%14.59M
-270.40%-3.02M
517.39%8.13M
383.94%5.6M
508.16%3.87M
547.48%4.88M
7,595.65%1.77M
433.20%1.32M
250.91%1.16M
-General and administrative expense
6.78%1.39M
151.81%16.64M
296.80%12.54M
7.69%1.5M
24.40%1.31M
28.90%1.3M
46.33%6.61M
124.52%3.16M
32.95%1.39M
0.48%1.05M
Research and development costs
-32.30%2.49M
-28.99%12.52M
-9.56%3.1M
-37.58%2.73M
-44.28%3.01M
-16.93%3.68M
-9.44%17.63M
-33.09%3.43M
-11.25%4.37M
4.98%5.4M
Depreciation amortization depletion
----
800.00%351K
----
----
----
----
-7.14%39K
----
----
----
-Depreciation and amortization
----
800.00%351K
----
----
----
----
-7.14%39K
----
----
----
Operating profit
45.55%-4.82M
-47.45%-42.99M
-41.27%-11.86M
-74.58%-12.36M
-30.43%-9.92M
-45.68%-8.86M
-17.68%-29.16M
-27.28%-8.4M
-13.85%-7.08M
-16.72%-7.6M
Net non-operating interest income expense
6.67%-364K
85.51%-162K
404.43%1.65M
-232.28%-525K
-200.00%-897K
-227.73%-390K
-53.36%-1.12M
-139.82%-542K
24.40%-158K
-166.96%-299K
Non-operating interest income
5.21%565K
189.19%2.01M
63.93%718K
186.24%312K
450.00%440K
701.49%537K
150.54%694K
2,090.91%438K
109.62%109K
-38.46%80K
Non-operating interest expense
0.22%929K
20.04%2.14M
-200.31%-957K
213.48%837K
252.77%1.34M
398.39%927K
81.50%1.79M
424.18%954K
2.30%267K
56.61%379K
Total other finance cost
----
-3.85%25K
----
----
----
----
18.18%26K
----
----
----
Other net income (expense)
253.98%4.49M
-427.97%-17.46M
-214.40%-3.67M
-907.46%-3.14M
-1,788.43%-7.73M
-329.97%-2.92M
443.93%5.32M
27.34%3.21M
-45.21%389K
311.06%458K
Gain on sale of security
----
-280.84%-10.99M
----
----
----
----
467.53%6.08M
----
----
----
Special income (charges)
----
---6.7M
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
--6.7M
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
253.98%4.49M
131.13%235K
588.68%14.03M
-907.46%-3.14M
-1,788.43%-7.73M
-329.97%-2.92M
-812.26%-755K
-168.76%-2.87M
-45.21%389K
311.06%458K
Income before tax
94.28%-696K
-142.94%-60.62M
-142.28%-13.89M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
7.77%-24.95M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
Income tax
Net income
94.28%-696K
-142.94%-60.62M
-142.28%-13.89M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
7.77%-24.95M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
Net income continuous Operations
94.28%-696K
-142.94%-60.62M
-142.28%-13.89M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
7.77%-24.95M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
Minority interest income
Net income attributable to the parent company
94.28%-696K
-142.93%-60.61M
-142.26%-13.88M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
7.77%-24.95M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
94.28%-696K
-142.93%-60.61M
-142.26%-13.88M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
7.77%-24.95M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
Basic earnings per share
93.59%-0.0096
-100.00%-0.9
-0.15
-100.00%-0.3
-100.00%-0.3
0.00%-0.15
25.00%-0.45
0
0.00%-0.15
0.00%-0.15
Diluted earnings per share
93.59%-0.0096
-100.00%-0.9
-0.15
-100.00%-0.3
-100.00%-0.3
0.00%-0.15
25.00%-0.45
0
0.00%-0.15
0.00%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 6.86M4.8M4.8M0000000
Operating revenue --6.86M--4.8M--4.8M--0--0--0--0--0--0--0
Cost of revenue 1.46M3.69M00
Gross profit 5.4M1.11M00
Operating expense 15.42%10.22M51.25%44.1M54.47%12.97M74.58%12.36M30.43%9.92M45.68%8.86M17.68%29.16M27.28%8.4M13.85%7.08M16.72%7.6M
Selling and administrative expenses 49.42%7.73M171.83%31.23M93.12%9.52M255.48%9.63M213.05%6.91M214.60%5.17M118.05%11.49M244.69%4.93M109.35%2.71M60.63%2.21M
-Selling and marketing expense 63.71%6.34M198.91%14.59M-270.40%-3.02M517.39%8.13M383.94%5.6M508.16%3.87M547.48%4.88M7,595.65%1.77M433.20%1.32M250.91%1.16M
-General and administrative expense 6.78%1.39M151.81%16.64M296.80%12.54M7.69%1.5M24.40%1.31M28.90%1.3M46.33%6.61M124.52%3.16M32.95%1.39M0.48%1.05M
Research and development costs -32.30%2.49M-28.99%12.52M-9.56%3.1M-37.58%2.73M-44.28%3.01M-16.93%3.68M-9.44%17.63M-33.09%3.43M-11.25%4.37M4.98%5.4M
Depreciation amortization depletion ----800.00%351K-----------------7.14%39K------------
-Depreciation and amortization ----800.00%351K-----------------7.14%39K------------
Operating profit 45.55%-4.82M-47.45%-42.99M-41.27%-11.86M-74.58%-12.36M-30.43%-9.92M-45.68%-8.86M-17.68%-29.16M-27.28%-8.4M-13.85%-7.08M-16.72%-7.6M
Net non-operating interest income expense 6.67%-364K85.51%-162K404.43%1.65M-232.28%-525K-200.00%-897K-227.73%-390K-53.36%-1.12M-139.82%-542K24.40%-158K-166.96%-299K
Non-operating interest income 5.21%565K189.19%2.01M63.93%718K186.24%312K450.00%440K701.49%537K150.54%694K2,090.91%438K109.62%109K-38.46%80K
Non-operating interest expense 0.22%929K20.04%2.14M-200.31%-957K213.48%837K252.77%1.34M398.39%927K81.50%1.79M424.18%954K2.30%267K56.61%379K
Total other finance cost -----3.85%25K----------------18.18%26K------------
Other net income (expense) 253.98%4.49M-427.97%-17.46M-214.40%-3.67M-907.46%-3.14M-1,788.43%-7.73M-329.97%-2.92M443.93%5.32M27.34%3.21M-45.21%389K311.06%458K
Gain on sale of security -----280.84%-10.99M----------------467.53%6.08M------------
Special income (charges) -------6.7M------------------0------------
-Less:Impairment of capital assets ------6.7M------------------0------------
Other non- operating income (expenses) 253.98%4.49M131.13%235K588.68%14.03M-907.46%-3.14M-1,788.43%-7.73M-329.97%-2.92M-812.26%-755K-168.76%-2.87M-45.21%389K311.06%458K
Income before tax 94.28%-696K-142.94%-60.62M-142.28%-13.89M-134.01%-16.02M-149.16%-18.55M-146.69%-12.16M7.77%-24.95M-33.16%-5.73M-19.79%-6.85M-8.78%-7.44M
Income tax
Net income 94.28%-696K-142.94%-60.62M-142.28%-13.89M-134.01%-16.02M-149.16%-18.55M-146.69%-12.16M7.77%-24.95M-33.16%-5.73M-19.79%-6.85M-8.78%-7.44M
Net income continuous Operations 94.28%-696K-142.94%-60.62M-142.28%-13.89M-134.01%-16.02M-149.16%-18.55M-146.69%-12.16M7.77%-24.95M-33.16%-5.73M-19.79%-6.85M-8.78%-7.44M
Minority interest income
Net income attributable to the parent company 94.28%-696K-142.93%-60.61M-142.26%-13.88M-134.01%-16.02M-149.16%-18.55M-146.69%-12.16M7.77%-24.95M-33.16%-5.73M-19.79%-6.85M-8.78%-7.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 94.28%-696K-142.93%-60.61M-142.26%-13.88M-134.01%-16.02M-149.16%-18.55M-146.69%-12.16M7.77%-24.95M-33.16%-5.73M-19.79%-6.85M-8.78%-7.44M
Basic earnings per share 93.59%-0.0096-100.00%-0.9-0.15-100.00%-0.3-100.00%-0.30.00%-0.1525.00%-0.4500.00%-0.150.00%-0.15
Diluted earnings per share 93.59%-0.0096-100.00%-0.9-0.15-100.00%-0.3-100.00%-0.30.00%-0.1525.00%-0.4500.00%-0.150.00%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg